Abstract Background HTLV-1-associated myelopathy/tropical spastic paraparesis
(HAM/TSP) is a progressive neurological and inflammatory disease, associated with HTLV-1 …

Around ten million people are infected with HTLV-1 worldwide, and 1–4% develop HTLV-1-
associated myelopathy/tropical spastic paraparesis (HAM/TSP), characterized by an …

HTLV‐1 is the etiologic agent of ATL and HAM/TSP. The majority of HTLV‐1‐infected
individuals remain asymptomatic, indicating that the infection alone is not sufficient to cause …

The lifetime risk of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
development differs among ethnic groups. To better understand these differences, this …

Most human T-lymphotropic virus type 1 (HTLV-1)-infected patients remain asymptomatic
throughout life. The factors associated with HTLV-1-associated myelopathy/tropical spastic …

The human T-lymphotropic virus 1 (HTLV-1) is the causative agent of HTLV-1-associated
myelopathy/tropical spastic paraparesis (HAM/TSP). The present study investigated the …

The present study investigated the association between the rs12979860 polymorphism in
the IL‐28B gene and HTLV‐1 infection as well as the development of HTLV‐1‐associated …

OBJECTIVE: To identify clinical and immunological markers associated with HTLV-I
associated myelopathy/tropical spastic paraparesis (HAM/TSP). METHOD: 237 HTLV-I …

Background Human T-cell lymphotropic virus type 1 (HTLV-1), also denominated Human T-
cell leukemia virus-1, induces immune activation and secretion of proinflammatory …

Abstract HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) develops in
less than 5% of HTLV-1 carriers. It is unclear which factors trigger the development of …